ASPEN PHARMACARE HOLDINGS LIMITED - Resignation of Executive Director

Resignation of Executive Director

ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
Registration number: 1985/002935/06
Share code: APN
ISIN: ZAE000066692
LEI: 635400ZYSN1IRD5QWQ94
and its subsidiaries (collectively "Aspen" or "the Company" or "the Group")


RESIGNATION OF EXECUTIVE DIRECTOR

Shareholders are notified that Mr Reginald Haman has resigned as Group Chief Corporate Officer, effective 31
July 2026, and will step down from the Aspen Pharmacare Holdings Limited Board as Executive Director on 1
May 2026, due to his plans to relocate to the Western Cape permanently.

The Board expresses its sincere appreciation to Mr Haman for his valuable contributions and dedicated service
to Aspen during his tenure as an executive and as director. His leadership has played a significant role in the
success and development of the Group.

Aspen and Mr Haman have agreed that, following his resignation, he will remain available to the Group on a
consulting basis for a period of 12 months. This arrangement is intended to ensure continuity and support a
smooth transition which will enable the Group to continue to benefit from his expertise.

The Board wishes Mr Haman continued success in his future endeavors.

Durban

30 April 2026

Sponsor
Investec Bank Limited

Date: 30-04-2026 09:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.